Reaktionsgleichung
[C:1]([OH:16])(=O)[CH2:2][CH2:3][CH2:4][CH2:5][S:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][S:12][CH2:13][CH3:14].C(Cl)(=O)CCCCSCCCCCSCC.COCCCCCCCCCCCC(Cl)=O.COCCCCCCCCCCCC([NH2:64])=O>>[C:1]([NH2:64])(=[O:16])[CH2:2][CH2:3][CH2:4][CH2:5][S:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][S:12][CH2:13][CH3:14]Komponenten
5
Versuchsvorschrift
When 6,12-dithiatetradecanoic acid is substituted for an equivalent amount of 12-methoxydoecanoic acid in Example 11 and then the resulting 6,12-dithiatetradecanoyl chloride is substituted for an equivalent amount of the 12-methoxydodecanoyl chloride in Example 12, the compound 6,12-dithiatetradecanamide is prepared and can be used in place of the 12-methoxy-dodecanamide with substantially similar antiviral results.
Quellen und Nachweise
- ORD-Eintrag
- ord-8f53d2e440ea4c25a236d33d087da32f
- Quelldatensatz
- uspto-grants-1999_01
- Patentnummer
- US05859052
Verknüpfte Notizen
Wird geladen…